









Markets
/
Stocks
/
nasdaq-ppbt
/

Purple Biotech Ltd

PPBT

View Detailed Chart

2.330USD

-0.290-11.07%

Close 07/25, 16:00（ET）Quotes delayed by 15 min

1.24BMarket Cap

LossP/E TTM



Purple Biotech Ltd

2.330

-0.290-11.07%

Overview Company Financials

Financials

Intraday

30m

Today

-11.07%

5 Days

-10.38%

1 Month

-0.00%

6 Months

-36.34%

Year to Date

-50.32%

1 Year

-70.87%

View Detailed Chart

Agency Rating

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(10)

Neutral(1)

Buy(1)

Indicators

Sell(4)

Neutral(1)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.003

Buy

RSI(14)

40.945

Neutral

STOCH(KDJ)(9,3,3)

37.202

Sell

ATR(14)

0.180

High Vlolatility

CCI(14)

-115.551

Sell

Williams %R

85.075

Oversold

TRIX(12,20)

0.344

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

2.641

Sell

MA10

2.586

Sell

MA20

2.502

Sell

MA50

2.471

Sell

MA100

2.536

Sell

MA200

3.074

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

Ticker SymbolPPBT

CompanyPurple Biotech Ltd

CEOMr. Gil Efron, CPA

Websitehttps://purple-biotech.com/